H.B. Fuller Company reports developments in its global adhesives, sealants and functional coatings business under NYSE symbol FUL. News commonly covers quarterly and annual results, gross margin trends, pricing and raw-material cost actions, dividends on common stock, and portfolio or footprint initiatives tied to Project Quantum Leap.
The company serves packaging, converting, hygiene, health and beauty, construction, engineering and aerospace-related applications through specialty industrial adhesive technologies. Updates also include manufacturing investments, supply-continuity actions, and customer support for regulated markets such as aviation, space and defense.
H.B. Fuller (NYSE: FUL) will implement a global minimum 10% price increase across all product lines effective April 1, 2026, with larger increases for certain technologies and regions. The action responds to petrochemical industry constraints that are affecting raw material availability and costs.
The company says it is securing materials early, reallocating supply regionally and qualifying alternative materials to maintain customer continuity and service while investing in operational resilience.
H.B. Fuller (NYSE: FUL) will report results for the three-month fiscal period ended February 28, 2026 in a press release after market close on March 25, 2026. The company will host an investor conference call on March 26, 2026 at 9:30 a.m. CT (10:30 a.m. ET).
Investors may listen via a live webcast with a supplemental presentation at the company investor website; registration is required. A telephone replay will be available from 12:30 p.m. CT on March 26 through 10:59 p.m. CT on April 2, 2026 using Conference ID 6370505.
H.B. Fuller (NYSE: FUL) announced a regular quarterly cash dividend of $0.2350 per share, payable on February 19, 2026 to shareholders of record at the close of business on February 5, 2026. The company has paid quarterly cash dividends on its common stock for 58 consecutive years.
H.B. Fuller (NYSE: FUL) reported Q4 2025 net revenue of $895M and net income of $30M, with adjusted EBITDA of $170M (up 14.6% YoY) and adjusted EPS of $1.28 (up 39.1% YoY). Fiscal 2025 net revenue was $3.47B and adjusted EBITDA $621M (up 4.5% YoY) with adjusted EPS of $4.24 (up 10.4% YoY). Adjusted gross margin expanded and adjusted EBITDA margin reached 17.9% for FY 2025. Net debt was $1.91B (net debt/adjusted EBITDA 3.1x). Fiscal 2026 outlook: net revenue flat to +2% and adjusted EBITDA of $630M–$660M.
H.B. Fuller (NYSE: FUL) will release fourth quarter and fiscal year 2025 results for the periods ended November 29, 2025 after market close on January 14, 2026.
The company will hold an investor conference call on January 15, 2026 at 9:30 a.m. CT (10:30 a.m. ET), available via live webcast and archived on the company investor website. A telephone replay will be available from 12:30 p.m. CT on January 15, 2026 through 10:59 p.m. CT on January 22, 2026 (Conference ID: 6370505).
H.B. Fuller (NYSE: FUL) launched Fuller Impact on October 13, 2025, transforming its foundation into a global platform that unites philanthropic investments and community engagement.
The program focuses grantmaking on STEM education and youth leadership, expands global reach aligned to the company’s footprint in 45+ countries, and adds employee-focused support including volunteer councils, matching donations, and service events. In 2024, employees volunteered 6,600 hours across 21 countries.
H.B. Fuller (NYSE: FUL) appointed Celine Martin to its Board of Directors, effective December 1, 2025. Ms. Martin brings more than 30 years of global MedTech experience, including roles as Company Group Chairman of Cardiovascular & Specialty Solutions at Johnson & Johnson from 2022–2025 and oversight of Ethicon's surgical instrument portfolio from 2018–2021. Her addition is described as reinforcing H.B. Fuller’s strategy to expand in high‑margin medical adhesive markets and to support the company’s transformation goal of achieving a greater than 20% EBITDA margin.
Ms. Martin holds an MBA from Wake Forest and a marketing graduate degree from EM Normandie; the appointment is positioned as strengthening governance and medical-market expertise to drive long‑term shareholder value.
H.B. Fuller (NYSE: FUL) will host its 2025 Investor Day on October 20, 2025 at the Conrad New York Downtown Hotel in New York.
Management, including President and CEO Celeste Mastin, will present a comprehensive update on the company’s strategic vision, financial performance, and long-term value creation plan. In-person attendance is invitation only due to limited capacity.
The event will be broadcast live via webcast at 1:00 P.M. Eastern on the company investor site https://investors.hbfuller.com, and a replay plus presentation materials will be archived on the site.
H.B. Fuller (NYSE: FUL) announced a regular quarterly cash dividend of $0.2350 per share, payable on October 30, 2025 to shareholders of record at the close of business on October 16, 2025. The company has paid quarterly cash dividends for 57 consecutive years.
H.B. Fuller (NYSE: FUL) reported strong Q3 2025 financial results with notable margin expansion and EPS growth. The company achieved adjusted EPS of $1.26, up 12% year-on-year, and adjusted EBITDA of $171 million, a 3% increase, with margin expanding to 19.1%.
Net revenue was $892 million, down 2.8% year-over-year, though organic revenue grew 1.6% excluding the flooring divestiture. The company demonstrated strong operational efficiency with adjusted gross profit margin increasing 190 basis points to 32.3%. Cash flow from operations improved 13% to $99 million, while net debt decreased to $1,958 million with a leverage ratio of 3.3X.
Due to challenging macroeconomic conditions, H.B. Fuller updated its FY2025 guidance, expecting net revenue to decline 2-3% and adjusted EBITDA to reach $615-625 million, representing 4-5% growth.